We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Landmark Development Agreement Signed Between PDA and St. Petersburg State Chemical-Pharmaceutical Academy

By LabMedica International staff writers
Posted on 26 Jul 2012
Print article
The Parenteral Drug Association (PDA; Bethesda, MD, USA) and the Saint-Petersburg State Chemical-Pharmaceutical Academy (SPCPA; St. Petersburg, Russia) have signed a memorandum of understanding to develop a Good Manufacturing Practices (GMP) and Regulatory Affairs Training Center in the area of pharmaceutical manufacturing, an important step in implementing higher standards of quality production in Russia by advancing its pharmaceutical manufacturing technology and quality control.

The Training Center, located in St. Petersburg, will carry out ongoing hands-on training programs for Russian GMP inspectors, SPCPA students, Russian pharmaceutical manufacturers, and professionals of the healthcare industry to improve knowledge and implementation of current GMP. The project will also facilitate the exchange of experience and information on relevant legislation and regulatory procedures. The knowledge gained by students during education in the St. Petersburg Academy will be used to conduct inspections of the pharmaceutical industry in Russia, as measures to help ensure a proper level of quality and efficiency of medical care to meet, as the primary priority, the interests of Russian and guest patients.

This timely project is supported by the government of St. Petersburg and the Ministry of Industry and Trade of the Russian Federation. Richard M. Johnson, PDA President said, "With 600+ pharmaceutical manufacturing plants in Russia it is clear that Russia has made it a priority to enhance understanding and implementing internationally consistent current GMPs. PDA considers this project critical to the overall health of the global pharmaceutical pipeline since there will be more and more of a push for international pharmaceutical companies to partner for manufacturing.” He added, “We are pleased that the SPCPA decided to choose PDA as their premier partner in this significant endeavor.”

Related Links:

Parenteral Drug Association
St. Petersburg State Chemical-Pharmaceutical Academy



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.